COVID-19 and the need for stringent rules on data sharing
Keywords:
COVID-19, Retractions, Publication Frauds, Data sharing, Publication ethicsAbstract
This communication refers to the retractions of the two high profile COVID-19 papers of the top medical journals when the data analytics company declined to share the raw data of the papers. In this commentary, we emphasize that it is very pertinent for the journals to mandatorily ask the authors for sharing of the primary data. This will ensure data integrity and transparency of the research findings, and help in negating the publication frauds.
References
Mehra MR, Desai SS, Kuy S, Henry TD, Patel AN. Cardiovascular disease, drug therapy, and mortality in Covid-19. N Engl J Med 2020;382:e102-e102. DOI: 10.1056/NEJMoa2007621 (Retracted)
Mehra MR, Desai SS, Ruschitzka F, Patel AN. Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis, Lancet 2020, DOI: 10.1016/S0140-6736(20)31180-6 (Retracted)
Ledford H, Van Noorden R. High profile coronavirus retractions raise concerns about data oversight. Nature 200, 582, 488, doi: 10.1038/d41586-020-01695-w
Yeo-The NSL. Tang BL. An alarming retraction rate for scientific publications on Coronavirus Disease 2019 (COVID-19). Account Res 2020, doi: 10.1080/08989621.2020.1782203

Downloads
Published
Issue
Section
License
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.